The role of miRNAs in alveolar epithelial cells in emphysema

Biomed Pharmacother. 2021 Nov:143:112216. doi: 10.1016/j.biopha.2021.112216. Epub 2021 Sep 27.

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease becoming one of the leading causes of mortality and morbidity globally. The significant risk factors for COPD are exposure to harmful particles such as cigarette smoke, biomass smoke, and air pollution. Pulmonary emphysema belongs to COPD and is characterized by a unique alveolar destruction pattern resulting in marked airspace enlargement. Alveolar type II (ATII) cells have stem cell potential; they proliferate and differentiate to alveolar type I cells to restore the epithelium after damage. Oxidative stress causes premature cell senescence that can contribute to emphysema development. MiRNAs regulate gene expression, are essential for maintaining ATII cell homeostasis, and their dysregulation contributes to this disease development. They also serve as biomarkers of lung diseases and potential therapeutics. In this review, we summarize recent findings on miRNAs' role in alveolar epithelial cells in emphysema.

Keywords: Alveolar epithelial cells; Biomarkers; Emphysema; MiRNA.

Publication types

  • Review

MeSH terms

  • Alveolar Epithelial Cells / drug effects
  • Alveolar Epithelial Cells / metabolism*
  • Alveolar Epithelial Cells / pathology
  • Animals
  • Biomarkers / metabolism
  • Cell Proliferation
  • Disease Models, Animal
  • Gene Expression Regulation
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Molecular Targeted Therapy
  • Oxidative Stress
  • Pulmonary Emphysema / drug therapy
  • Pulmonary Emphysema / etiology
  • Pulmonary Emphysema / genetics
  • Pulmonary Emphysema / metabolism*
  • Signal Transduction
  • Smoking / adverse effects*

Substances

  • Biomarkers
  • MicroRNAs